Long-Acting Growth Hormone Therapy in Pediatric Growth Hormone Deficiency: A Consensus Statement

• by Aristides Maniatis, Wayne Cutfield, Mehul Dattani, Cheri Deal, Paulo Ferrez Collett-Solberg, Reiko Horikawa, Mohamad Maghnie, Bradley S Miller, Michel Polak, Lars Sävendahl, Joachim Woelfle

• December 3, 2024

Diabetes Risk Scores: Beyond Glucose

Multi-ancestry polygenic models identify high-risk patients traditional screening may miss.

• by Kathryn Wighton

• May 13, 2026

• 5 min

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

• by Kathryn Wighton

• May 27, 2026

• 5 min

Increasing incidence and severity of childhood-onset type 1 diabetes in Latvia during the COVID-19 pandemic

• by Lizete Braivo, Viktorija Truškova, Aļona Lavrenova, Anda Ķīvīte-Urtāne, Jana Pavāre, Iveta Dzīvīte-Krišāne

• May 22, 2026